Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lidocaine hydrochloride (Local Anaesthesia)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lidocaine 5% / Cetrimide 0.15% oromucosal gel sugar free
1502010J0AAETET
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 3 |
|
Lidocaine 5% gel
1502010J0AABVBV
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 3 |
|
Lidocaine 100mg/5ml (2%) inj pre-filled syringes
1502010J0AAEBEB
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 1 |
|
Lidocaine 1% and Chlorhexidine gel
1502010J0AABKBK
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 100mg/Adrenaline (base) 100microg/20ml inj vials
1502010J0AAA7A7
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 150mg/g / Cetrimide 1.5mg/g oromucosal spy SF
1502010J0AAESES
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 160mg/4ml (4%) oromucosal soln pre-filled syringes
1502010J0AAEAEA
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 42mg/ml intrauterine gel
1502010J0AAEUEU
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine hydrochlor 0.6%/Cetylpyr chlor 0.02% gel SF
1502010J0AAEKEK
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.